Summary of Classification and Labelling
Notified classification and labelling
General Information
638-855-2 |
Orbifloxacin |
113617-63-3 |
Notified classification and labelling according to CLP criteria
Repr. 2 |
H361
(H361d: Suspecte...)
|
H361
|
|
GHS08 Wng
|
|
|
|
|
35 |
|
View details
|
Repr. 2 |
H361
(Suspected of da...)
|
H361
(Suspected of da...)
|
|
GHS08 Wng
|
|
|
|
|
11 |
|
View details
|
Number of Aggregated Notifications: 2